Coronavirus/COVID-19… impacts accounting, auditing and financial reporting.

Andy Mintzer, CPA

The Coronavirus pandemic has caused considerable damage to the health and security of people all over the world.  The substantial harm of the pandemic is yet to be measured.  But while worldwide efforts to stem the growth of the virus continue there are still required financial reports that must be issued within deadlines.

This posting discusses some of resources and relief available to accountants, financial statement preparers and auditors as a result of the COVID-19 pandemic.  I will also discuss some accounting and auditing-related issues that have been raised. Keep in mind, of course, that this situation is evolving, and the information is subject to change or extension.  This posting includes sections on:

  • Public Companies – and guidance issued by the SEC and SEC staff
  • Audits of financial statements – and the resources made available by the AICPA
  • Going Concern Considerations – an update to my posting in 2019 on this topic

Public Companies – SEC offers both guidance and potential to extend deadlines for required financial reporting.

Annual Form 10-K filing deadlines pushed back to provide relief for companies and auditors in completing calendar 2019 annual reports.

Worldwide securities markets saw significant drops in late February which caused significant uncertainty and constrained the resources of those with upcoming filing deadlines.  The first major deadline for the annual Form 10-K for was for Large Accelerated Filer (companies with a public float of more than $700 million) – and it was March 2, 2020.  The Securities and Exchange Commission (SEC) provided financial reporting relief on March 4, 2020 which generally pushed back the deadlines for all filers for 45 days; thus any filer who did not file its form timely had an additional 45 days (or until April 16, 2020) to timely file its Form 10-K.  Here is what happened to the rest of the 10-K deadlines:

Filer CategoryOriginal Form 10-K DeadlineRevised deadline with SEC relief
Accelerated FilerMarch 16, 2020April 30, 2020
Non-Accelerated Filer and othersMarch 30, 2020May 14, 2020
Summarized potential impact of SEC deadline relief

This relief is not automatic and without conditions.  Among other conditions, companies must convey through a current report a summary of why the relief is needed in their particular circumstances. The On March 25, 2020 the Commission issued an order that, subject to certain conditions, provides public companies with a 45-day extension to file certain disclosure reports that would otherwise have been due between March 1 and July 1, 2020.  The SEC encourages companies and their representatives to contact SEC staff with questions or matters of particular concern in this regard.

In providing this deadline extension, SEC Chairman Clayton said:

“How companies plan and respond to the events as they unfold can be material to an investment decision, and I urge companies to work with their audit committees and auditors to ensure that their financial reporting, auditing and review processes are as robust as practicable in light of the circumstances in meeting the applicable requirements.”

Companies should consider the need for COVID-19-related disclosures. 

On March 25 the Division of Corporation Finance (Division) published disclosure guidance related to Coronavirus/COVID-19 consequences affecting SEC registrants while recognizing that the impact on companies is evolving rapidly and its future effects are uncertain (March 25 SEC Release).  The Division is monitoring how companies are reporting the effects and risks of COVID-19.  

In the March 25 SEC Release the Division encouraged timely reporting while recognizing that it may be difficult to assess or predict with precision the broad effects of COVID-19 on industries or individual companies.  Although the Division acknowledged that the actual impact depends on many factors that are beyond a company’s control and knowledge, the effects COVID-19 has had on a company, what management expects its future impact will be, how management is responding to evolving events, and how it is planning for COVID-19-related uncertainties can be material to investment and voting decisions.

SEC disclosure requirements apply to a broad range of evolving business risks even in the absence of a specific line item requirement that names the particular risk presented; for example, the SEC has highlighted that although no existing disclosure requirement specifically refers to cybersecurity risks and cyber incidents, a number of requirements may impose an obligation on companies to disclose such risks and incidents (See Release No. 33-10459 (Feb. 26, 2018))

In addition, a number of long-standing existing accounting related rules or regulations require disclosure about the known or reasonably likely effects of and the types of risks presented by COVID-19.  As a result, disclosure of these risks and COVID-19-related effects may be necessary or appropriate in one or more of the following portions of a Form 10-K:

  • Management’s discussion and analysis, 
  • Business section, 
  • Risk factors, 
  • Legal proceedings, 
  • Disclosure controls and procedures, 
  • Internal control over financial reporting
  • Financial statements

Assessing and Disclosing the evolving impact

The March 25 SEC Release also provides guidance to companies as they assess the evolving effects of COVID-19 and related risks will be a facts and circumstances analysis – not a boilerplate one-size-fits-all disclosure.

Disclosure about these risks and effects, including how the company and management are responding to them, should be specific to each company.  As companies assess COVID-19-related effects and consider their disclosure obligations, the SEC has provided questions to consider, including:

  • How has COVID-19 impacted  financial condition and results of operations?  What are expected impacts to future operating results and near-and-long-term financial condition?  Is the expected impact to future operations different than how it affected the current period?
  • How has COVID-19 impacted capital and financial resources, including the overall liquidity position and outlook?  
  • Is there a material uncertainty about the ongoing ability to meet the covenants of credit agreements?  
  • If a material liquidity deficiency has been identified, what course of action has the company taken or proposed to take?  (Consider the requirement to disclose known trends and uncertainties)
  • Does the company expect to disclose or incur any material COVID-19-related contingencies?
  • Will COVID-19 issues affect assets or the company’s ability to timely account for those assets?  (For example, will there be significant changes in judgments in determining the fair-value of assets)
  • Are material impairments anticipated (e.g., with respect to goodwill, intangible assets, long-lived assets, right of use assets, investment securities)? 
  • Are increases in allowances for credit losses, restructuring charges, other expenses, or changes in accounting judgments that have had or are reasonably likely to have a material impact on the financial statements anticipated?
  • Have COVID-19-related circumstances adversely affected financial reporting systems, internal control over financial reporting (ICFR) and disclosure controls and procedures?  If so, what changes in controls have occurred during the current period that materially affect or are reasonably likely to materially affect ICFR?  
  • Is there an expectation that demand for products or services will be adversely affected?
  • Is a material adverse impact to the supply chain or the methods used to distribute products or services anticipated? 
  • Are travel restrictions and border closures expected to have a material?

As published by the SEC, the above list is illustrative but not exhaustive and each company will need to carefully assess COVID-19’s impact and related material disclosure obligations.  The Division encourages disclosure that is tailored and provides material information about the impact of COVID-19 to investors and market participants.  

SEC Registrants…Reporting Earnings and Financial Results

“The ongoing and evolving COVID-19 impact will likely make it more difficult for companies and their auditors to complete the work required to maintain timely filings and we encourage companies to proactively address financial reporting matters earlier than usual.  For example, to the extent a company or its auditors will need to consult with experts to determine how the evolving COVID-19 situation may impact its assets, including impairment of goodwill or other assets, it should consider engaging with those experts promptly so that its reporting remains as timely as possible, as well as complete and accurate.”

According to the March 25 SEC Release

In this section I will summarize some of the highlights from the March 25 SEC Release as it relates to reporting earnings and financial results.

Although not required to do so, companies often release earnings estimates and other financial results in advance of finalizing the required financial reporting for the relevant period.  There may be instances where a GAAP financial measure is not available at the time of the earnings release because the measure may be impacted by COVID-19-related adjustments that may require additional information and analysis to complete.  In these situations, the Division disclosed that it would not object to companies reconciling a non-GAAP financial measure to preliminary GAAP results that either include provisional amount(s) based on a reasonable estimate, or a range of reasonably estimable GAAP results.  For example, under this position, if a company intends to disclose on an earnings call its earnings before interest, taxes, depreciation and amortization (EBITDA), it could reconcile that measure to either its GAAP earnings, a reasonable estimate of its GAAP earnings that includes a provisional amount, or its reasonable estimate of a range of GAAP earnings.  The provisional amount or range should reflect a reasonable estimate of COVID-19 related charges not yet finalized, such as impairment charges.  A non-GAAP financial measure should not be disclosed more prominently than the most directly comparable GAAP financial measure or range of GAAP measures.  In addition, in filings where GAAP financial statements are required, such as filings on Form 10-K or 10-Q, companies should reconcile to GAAP results and not include provisional amounts or a range of estimated results.

To the extent a company presents a non-GAAP financial measure or performance metric to adjust for or explain the impact of COVID-19, it would be appropriate to highlight why management finds the measure or metric useful and how it helps investors assess the impact of COVID-19 on the company’s financial position and results of operations.  

In addition, if a company presents non-GAAP financial measures that are reconciled to provisional amount(s) or an estimated range of GAAP financial measures in reliance on the above position, it should limit the measures in its presentation to those non-GAAP financial measures it is using to report financial results to the Board of Directors.  The SEC’s release reminds companies that it does not believe it is appropriate for a company to present non-GAAP financial measures or metrics for the sole purpose of presenting a more favorable view of the company.  Rather, if used, companies should use non-GAAP financial measures and performance metrics for the purpose of sharing with investors how management and the Board are analyzing the current and potential impact of COVID-19 on the company’s results.  If a company presents non-GAAP financial measures that are reconciled to provisional amount(s) or an estimated range of GAAP financial measures, it should explain, to the extent practicable, why the line item(s) or accounting is incomplete, and what additional information or analysis may be needed to complete the accounting.

Companies may consider presenting metrics related to COVID-19, or changing the method by which it calculates a metric as a result of COVID-19.  In these cases, the SEC reminds companies of the principles explained in recent Commission guidance related to metrics, specifically Release No. 33-1075

Does the COVID-19 crisis affect audits of financial statements?

I am aware that many are asking how audits…those in-process or those yet-to-begin…might be impacted by the COVID-19 crisis.  

I will give this subject a very light touch in this posting, as this may be a very broad issue. Since many have asked about it I wanted to at least get the conversation started. The AICPA has published many resources which can be found here:


This link includes an accounting and auditing FAQ document.  The FAQ document addresses many accounting questions and the possible impact on the audits for a wide range of topics.  Some of the topics addressed are:

  • Access to Books and Records
  • Asset Impairments
  • Emphasis‐of‐Matter Paragraphs and Types of Auditor’s Reports
  • Fair Value of Investments
  • Fraud Inquiries
  • Going Concern
  • Internal Control
  • Inventory Observations
  • Management Representation Letters
  • Risks and Uncertainties
  • Subsequent Events

Going Concern Considerations

One of my prior posts included a discussion on going concern considerations.  Since I have seen many questions about how going concern considerations might be affected by COVID-19 I felt it appropriate to include this update.

GAAP (FASB ASC 205‐40) requires management to evaluate an entity’s ability to continue as a going concern within one year after the date the financialstatements are issued (or available to be issued, when applicable). Substantial doubt about an entity’s ability to continue as a going concern exists whenconditions and events, considered in the aggregate, indicate that it is probable that the entity will be unable to meet its obligations as they become due withinone year after the date that the financial statements are issued.  Disclosures in the notes to the financial statements are required if management concludes thatsubstantial doubt exists or that its plans alleviate that substantial doubt.

The ability of an entity to continue as a going concern is affected by many factors and the consequences of COVID‐19 may impact those factors as they relate to the particular audit client’s facts and circumstances.

Since the relevant period is generally one year from the date the financial statements are issued, the evolving effects of the COVID‐19 crisis may affect the evaluation of the audit client’s going concern evaluation.  These effects might impact some industries (restaurants, entertainment, airlines, etc.) more than others – but might also affect the customers and vendors of these industries as well.

The ability of an entity to continue as a going concern is affected by many factors, including the industry and geographic area in which the entity operates, thefinancial health of customers and suppliers of the entity, and the accessibility to financing that is available for the entity. The consequences of COVID‐19 mayimpact the factors in evaluating the ability of an entity to continue as a going concern.  They may cause a decline in an entity’s operating results and financialposition. As such, entities and auditors may need to evaluate the latest relevant information related to their assessments of going concern.  Consideration of liquidity received from government relief programs may also factor into the assessment.


Andrew M. Mintzer, CPA is a forensic accounting with the Los Angeles office of Hemming Morse, LLP.  He is a past chair of the California Society of Certified Public Accountants.

This article discusses GAAP and professional standards in general – I have not consider any specific situations.  The application of GAAP or auditing standards to a particular situation depends on the specific facts and circumstances and analysis of the applicable accounting or auditing standards.  Therefore this article is educational in nature and does not represent professional accounting or auditing advice or services